drugset / Trial / NCT00796432

A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone

NCT00796432

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purposes of this study are to estimate the relationship of D2-receptor occupancy to plasma concentration and to assess the safety of OROS paliperidone.

Timeline

Start
2003-03
Primary completion
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Paliperidone Unknown 6 mg Oral

Indications